Multiple sclerosis (MS) results in an extensive use of the health care system, even within the first years of diagnosis. The effectiveness and accessibility of the health care system may affect patients' quality of life. The aim of the present study was to evaluate the health care resource use of MS patients under interferon beta-1b (EXTAVIA) treatment in Greece, the demographic or clinical factors that may affect this use and also patient satisfaction with the health care system. Structured interviews were conducted for data collection. In total, 204 patients (74.02% females, mean age (SD) 43.58 (11.42) years) were enrolled in the study. Analysis of the reported data revealed that during the previous year patients made extensive use of health services in particular neurologists (71.08% visited neurologists in public hospitals, 66.67% in private offices and 48.53% in insurance institutes) and physiotherapists. However, the majority of the patients (52.45%) chose as their treating doctor private practice neurologists, which may reflect accessibility barriers or low quality health services in the public health system. Patients seemed to be generally satisfied with the received health care, support and information on MS (84.81% were satisfied from the information provided to them). Patients' health status (as denoted by disease duration, disability status and hospitalization needs) and insurance institute were found to influence their visits to neurologists. Good adherence (up to 70.1%) to the study medication was reported. Patients' feedback on currently provided health services could direct these services towards the patients' expectations.

In 2022, children and teens are over-represented as health center patients compared to their proportion in the population. This statistic depicts the age distribution of health center patients compared to overall U.S. population as of 2022.

1) Data Introduction • The Healthcare Dataset is a synthetic dataset designed to mimic real-world healthcare data for data science, machine learning, and data analysis purposes. It includes patient information, medical conditions, admission details, and healthcare services provided. This dataset is ideal for developing and testing healthcare predictive models, practicing data manipulation techniques, and creating data visualizations.

2) Data Utilization (1) Healthcare data has characteristics that: • It includes detailed patient information such as age, gender, blood type, medical condition, and admission details. This information can be used to analyze healthcare trends, patient demographics, and the effectiveness of medical treatments. (2) Healthcare data can be used to: • Predictive Modeling: Helps in developing models to predict patient outcomes, treatment success rates, and disease progression. • Healthcare Analytics: Assists in analyzing patient data to identify patterns, improve patient care, and optimize resource allocation. • Educational Purposes: Supports learning and teaching data science concepts in a healthcare context, providing realistic data for experimentation and practice.

These datasets are for a cohort of n=1540 anonymised hospitalised COVID-19 patients, and the data provide information on outcomes (i.e. patient death or discharge), demographics and biomarker measurements for two New York hospitals: State University of New York (SUNY) Downstate Health Sciences University and Maimonides Medical Center.

The file "demographics_both_hospitals.csv" contains the ultimate outcomes of hospitalisation (whether a patient was discharged or died), demographic information and known comorbidities for each of the patients.

The file "dynamics_clean_both_hospitals.csv" contains cleaned dynamic biomarker measurements for the n=1233 patients where this information was available and the data passed our various checks (see https://doi.org/10.1101/2021.11.12.21266248 for information of these checks and the cleaning process). Patients can be matched to demographic data via the "id" column.

Study approval and data collection

Study approval was obtained from the State University of New York (SUNY) Downstate Health Sciences University Institutional Review Board (IRB#1595271-1) and Maimonides Medical Center Institutional Review Board/Research Committee (IRB#2020-05-07). A retrospective query was performed among the patients who were admitted to SUNY Downstate Medical Center and Maimonides Medical Center with COVID-19-related symptoms, which was subsequently confirmed by RT PCR, from the beginning of February 2020 until the end of May 2020. Stratified randomization was used to select at least 500 patients who were discharged and 500 patients who died due to the complications of COVID-19. Patient outcome was recorded as a binary choice of “discharged” versus “COVID-19 related mortality”. Patients whose outcome was unknown were excluded. Demographic, clinical history and laboratory data was extracted from the hospital’s electronic health records.

Introduction

According to Healthcare Staffing Statistics, Healthcare staffing is a crucial facet of the healthcare industry, involving the recruitment, hiring, and management of qualified professionals to meet the ever-changing demands of patients and medical institutions. This intricate process plays a pivotal role in ensuring high-quality patient care by matching individuals' skills and qualifications to specific roles, considering factors like patient load and location.

Effective healthcare staffing requires anticipating staffing needs, managing schedules, addressing turnover, and adhering to regulatory standards. Inadequate staffing can jeopardize patient safety and care quality, while effective staffing enhances patient outcomes and experiences, making it a cornerstone of healthcare delivery.

In essence, healthcare staffing is a complex, indispensable process that directly impacts patient well-being and the overall success of healthcare organizations, demanding meticulous planning and unwavering commitment to excellent patient care.

The acute-care pathway (from the emergency department (ED) through acute medical units or ambulatory care and on to wards) is the most visible aspect of the hospital health-care system to most patients. Acute hospital admissions are increasing yearly and overcrowded emergency departments and high bed occupancy rates are associated with a range of adverse patient outcomes. Predicted growth in demand for acute care driven by an ageing population and increasing multimorbidity is likely to exacerbate these problems in the absence of innovation to improve the processes of care.

Key targets for Emergency Medicine services are changing, moving away from previous 4-hour targets. This will likely impact the assessment of patients admitted to hospital through Emergency Departments.

This data set provides highly granular patient level information, showing the day-to-day variation in case mix and acuity. The data includes detailed demography, co-morbidity, symptoms, longitudinal acuity scores, physiology and laboratory results, all investigations, prescriptions, diagnoses and outcomes. It could be used to develop new pathways or understand the prevalence or severity of specific disease presentations.

PIONEER geography: The West Midlands (WM) has a population of 5.9 million & includes a diverse ethnic & socio-economic mix.

Electronic Health Record: University Hospital Birmingham is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds & an expanded 250 ITU bed capacity during COVID. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health”.

Scope: All patients with a medical emergency admitted to hospital, flowing through the acute medical unit. Longitudinal & individually linked, so that the preceding & subsequent health journey can be mapped & healthcare utilisation prior to & after admission understood. The dataset includes patient demographics, co-morbidities taken from ICD-10 & SNOMED-CT codes. Serial, structured data pertaining to process of care (timings, admissions, wards and readmissions), physiology readings (NEWS2 score and clinical frailty scale), Charlson comorbidity index and time dimensions.

Available supplementary data: Matched controls; ambulance data, OMOP data, synthetic data.

Available supplementary support: Analytics, Model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.

The All CMS Data Feeds dataset is an expansive resource offering access to 119 unique report feeds, providing in-depth insights into various aspects of the U.S. healthcare system including nursing facility owners and accountable care organization participants contact data. With over 25.8 billion rows of data meticulously collected since 2007, this dataset is invaluable for healthcare professionals, analysts, researchers, and businesses seeking to understand and analyze healthcare trends, performance metrics, and demographic shifts over time. The dataset is updated monthly, ensuring that users always have access to the most current and relevant data available.

Dataset Overview:

118 Report Feeds: - The dataset includes a wide array of report feeds, each providing unique insights into different dimensions of healthcare. These topics range from Medicare and Medicaid service metrics, patient demographics, provider information, financial data, and much more. The breadth of information ensures that users can find relevant data for nearly any healthcare-related analysis. - As CMS releases new report feeds, they are automatically added to this dataset, keeping it current and expanding its utility for users.

25.8 Billion Rows of Data:

• With over 25.8 billion rows of data, this dataset provides a comprehensive view of the U.S. healthcare system. This extensive volume of data allows for granular analysis, enabling users to uncover insights that might be missed in smaller datasets. The data is also meticulously cleaned and aligned, ensuring accuracy and ease of use.

Historical Data Since 2007: - The dataset spans from 2007 to the present, offering a rich historical perspective that is essential for tracking long-term trends and changes in healthcare delivery, policy impacts, and patient outcomes. This historical data is particularly valuable for conducting longitudinal studies and evaluating the effects of various healthcare interventions over time.

Monthly Updates:

• To ensure that users have access to the most current information, the dataset is updated monthly. These updates include new reports as well as revisions to existing data, making the dataset a continuously evolving resource that stays relevant and accurate.

Data Sourced from CMS:

• The data in this dataset is sourced directly from the Centers for Medicare & Medicaid Services (CMS). After collection, the data is meticulously cleaned and its attributes are aligned, ensuring consistency, accuracy, and ease of use for any application. Furthermore, any new updates or releases from CMS are automatically integrated into the dataset, keeping it comprehensive and current.

Use Cases:

Market Analysis:

• The dataset is ideal for market analysts who need to understand the dynamics of the healthcare industry. The extensive historical data allows for detailed segmentation and analysis, helping users identify trends, market shifts, and growth opportunities. The comprehensive nature of the data enables users to perform in-depth analyses of specific market segments, making it a valuable tool for strategic decision-making.

Healthcare Research:

• Researchers will find the All CMS Data Feeds dataset to be a robust foundation for academic and commercial research. The historical data, combined with the breadth of coverage across various healthcare metrics, supports rigorous, in-depth analysis. Researchers can explore the effects of healthcare policies, study patient outcomes, analyze provider performance, and more, all within a single, comprehensive dataset.

Performance Tracking:

• Healthcare providers and organizations can use the dataset to track performance metrics over time. By comparing data across different periods, organizations can identify areas for improvement, monitor the effectiveness of initiatives, and ensure compliance with regulatory standards. The dataset provides the detailed, reliable data needed to track and analyze key performance indicators.

Compliance and Regulatory Reporting:

• The dataset is also an essential tool for compliance officers and those involved in regulatory reporting. With detailed data on provider performance, patient outcomes, and healthcare utilization, the dataset helps organizations meet regulatory requirements, prepare for audits, and ensure adherence to best practices. The accuracy and comprehensiveness of the data make it a trusted resource for regulatory compliance.

Data Quality and Reliability:

The All CMS Data Feeds dataset is designed with a strong emphasis on data quality and reliability. Each row of data is meticulously cleaned and aligned, ensuring that it is both accurate and consistent. This attention to detail makes the dataset a trusted resource for high-stakes applications, where data quality is critical.

Integration and Usability:

Ease of Integration:

• The dataset is provided in a CSV format, which is widely compatible with most data analysis too...

The COVID-19 pandemic and subsequent expansion of telehealth may be exacerbating inequities in ambulatory care access due to institutional and structural barriers. We conduct a repeat cross-sectional analysis of ambulatory patients to evaluate for demographic disparities in the utilization of telehealth modalities. The ambulatory patient population at Oregon Health & Science University (Portland, OR) is examined from June 1 through September 30, in 2019 (reference period) and in 2020 (study period). We first assess for changes in demographic representation and then evaluate for disparities in the utilization of telephone and video care modalities using logistic regression. Between the 2019 and 2020 periods, patient video utilization increased from 0.2% to 31%, and telephone use increased from 2.5% to 25%. There was also a small but significant decline in the representation males, Asians, Medicaid, Medicare, and non-English speaking patients. Amongst telehealth users, adjusted odds of video participation were significantly lower for those who were Black, American Indian, male, prefer a non-English language, have Medicaid or Medicare, or older. A large portion of ambulatory patients shifted to telehealth modalities during the pandemic. Seniors, non-English speakers, and Black patients were more reliant on telephone than video for care. The differences in telehealth adoption by vulnerable populations demonstrate the tendency towards disparities that can occur in the expansion of telehealth and suggest structural biases. Organizations should actively monitor the utilization of telehealth modalities and develop best-practice guidelines in order to mitigate the exacerbation of inequities.

Methods A repeat cross-sectional study was conducted of patients who utilized the ambulatory clinics at Oregon Health & Science University (OHSU) from June 1 through September 30, in 2019 (reference period) and 2020 (study period). The study period was chosen because it exhibited a relatively stable rate of in-person, telephone, and video ambulatory visits. The initial months of the pandemic in March through May 2020 were marked by shifting state and institutional policies that affected appointment availability. By the summer of 2020, clinics were more open to scheduling in-person visits. We chose to investigate a later, more stable time-frame for disparities because we believe that the analysis would be more indicative of ongoing trends.

Unique patient counts were extracted from ambulatory provider-led visits, defined as outpatient visits with physicians, nurse practitioners, or physician assistants. Visits modalities included in-person, video, or telephone, the latter two comprising telehealth. Patient demographics included ethnicity, race, preferred language, payer, age, and sex. The encounter-level data was aggregated by unique patient identifier into patient counts for the study period of June 1 through Sept 30, 2020. Table 1 displays unique patient counts of ambulatory care modality utilization (in-person, video, telephone, and any telehealth) for each demographic group (race, ethnicity, sex, preferred language, insurance, and age). There is also a column for total patients in that demographic group. In the main article, we performed logistic regression to evaluate the association of patient demographics with telehealth utilization. Table 2 displays unique patient counts of ambulatory care modality utilization for each demographic group only within primary care clinics.

Table 3 displays unique patient counts for each demographic group within the time periods before and during the COVID-19 pandemic: June 1 through Sept 30, 2019 and June 1 through Sept 30, 2020. In the study, we compared the proportional representation of demographic groups between before and during the pandemic to assess for overall changes in our patient population.

BackgroundSegmentation of heterogeneous patient populations into parsimonious and relatively homogenous groups with similar healthcare needs can facilitate healthcare resource planning and development of effective integrated healthcare interventions for each segment. We aimed to apply a data-driven, healthcare utilization-based clustering analysis to segment a regional health system patient population and validate its discriminative ability on 4-year longitudinal healthcare utilization and mortality data.MethodsWe extracted data from the Singapore Health Services Electronic Health Intelligence System, an electronic medical record database that included healthcare utilization (inpatient admissions, specialist outpatient clinic visits, emergency department visits, and primary care clinic visits), mortality, diseases, and demographics for all adult Singapore residents who resided in and had a healthcare encounter with our regional health system in 2012. Hierarchical clustering analysis (Ward’s linkage) and K-means cluster analysis using age and healthcare utilization data in 2012 were applied to segment the selected population. These segments were compared using their demographics (other than age) and morbidities in 2012, and longitudinal healthcare utilization and mortality from 2013–2016.ResultsAmong 146,999 subjects, five distinct patient segments “Young, healthy”; “Middle age, healthy”; “Stable, chronic disease”; “Complicated chronic disease” and “Frequent admitters” were identified. Healthcare utilization patterns in 2012, morbidity patterns and demographics differed significantly across all segments. The “Frequent admitters” segment had the smallest number of patients (1.79% of the population) but consumed 69% of inpatient admissions, 77% of specialist outpatient visits, 54% of emergency department visits, and 23% of primary care clinic visits in 2012. 11.5% and 31.2% of this segment has end stage renal failure and malignancy respectively. The validity of cluster-analysis derived segments is supported by discriminative ability for longitudinal healthcare utilization and mortality from 2013–2016. Incident rate ratios for healthcare utilization and Cox hazards ratio for mortality increased as patient segments increased in complexity. Patients in the “Frequent admitters” segment accounted for a disproportionate healthcare utilization and 8.16 times higher mortality rate.ConclusionOur data-driven clustering analysis on a general patient population in Singapore identified five patient segments with distinct longitudinal healthcare utilization patterns and mortality risk to provide an evidence-based segmentation of a regional health system’s healthcare needs.

Snapshot img

Population Health Management Market Size 2025-2029

The population health management market size is forecast to increase by USD 19.40 billion at a CAGR of 10.7% between 2024 and 2029.

The Population Health Management Market is experiencing significant growth, driven by the increasing adoption of healthcare IT solutions and the rising focus on personalized medicine. The implementation of electronic health records (EHRs) and other digital health technologies has enabled healthcare providers to collect and analyze large amounts of patient data, facilitating proactive care and population health management. Moreover, the trend towards personalized medicine, which aims to tailor healthcare treatments to individual patients based on their unique genetic makeup and health history, is further fueling the demand for PHM solutions. However, the high cost of installing and implementing these platforms poses a significant challenge for market growth.
Despite this, the potential benefits of PHM, including improved patient outcomes, reduced healthcare costs, and enhanced population health, make it an attractive area for investment and innovation. Companies seeking to capitalize on these opportunities must navigate the challenges of data privacy and security, interoperability, and integration with existing healthcare systems. By addressing these challenges and focusing on delivering actionable insights from patient data, PHM solution providers can help healthcare organizations optimize their resources, improve patient care, and ultimately, improve population health.

What will be the Size of the Population Health Management Market during the forecast period?

Request Free Sample

The market is experiencing significant growth, driven by the increasing focus on accountable care organizations (ACOs) and payer organizations to improve health outcomes and reduce costs. Healthcare professionals are leveraging big data, data analytics services, and clinical data integration to develop personalized care plans and implement intervention strategies for various populations. Telehealth services have become essential in population health management, enabling care coordination, health promotion, and health navigation for patients. Health equity is a critical factor in population health management, with a growing emphasis on addressing disparities and ensuring equal access to care.
Data security and interoperability standards are essential in population health management, as healthcare providers exchange sensitive patient data for risk adjustment, care pathways, and quality reporting. Data mining and data visualization tools are used to identify health behavior changes and lifestyle modifications, leading to better health outcomes. Consumer health technology, such as patient engagement tools and wearable technology, are playing an increasingly important role in population health management. Health coaching and evidence-based medicine are intervention strategies used to prevent diseases and improve health outcomes. In summary, the market in the US is characterized by the adoption of precision medicine, health literacy, clinical guidelines, and personalized care plans.
The market is driven by the need for care coordination, data analytics, and patient engagement to improve health outcomes and reduce costs. The use of data security, data mining, and interoperability standards ensures the effective exchange and utilization of health data.

How is this Population Health Management Industry segmented?

The population health management industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Component

  Software
  Services


End-user

  Large enterprises
  SMEs


Delivery Mode

  On-Premise
  Cloud-Based
  Web-Based
  On-Premise
  Cloud-Based


End-Use

  Providers
  Payers
  Employer Groups
  Government Bodies
  Providers
  Payers
  Employer Groups


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World

By Component Insights

The software segment is estimated to witness significant growth during the forecast period.

The market's software segment is experiencing significant growth and innovation. Healthcare organizations are utilizing these solutions to effectively manage and enhance the health outcomes of diverse populations. The software component incorporates various tools that collect, analyze, and utilize health data for informed decision-making. Population health management platforms gather data from multiple sources, such as electronic health records, claims data, and patient-generated data. These platforms employ advanced analytics to generate valuable insi

The dataset contains counts of inpatient visits leading to a discharge to hospice care. Inpatient visits included in the counts consist of individuals aged 18 or over with a discharge disposition leading to home or facility hospice care. The total counts per each individual year can be viewed based on different patient characteristics, including patient age groups, individual counties of residence, primary payer type, diagnosis category, and patient sex/race/ethnicity. The disease categories include circulatory conditions, diabetes, malignant/benign neoplasms, malnutrition, neurodegenerative disease, renal failure or other kidney diagnoses, respiratory conditions and circulatory conditions. The categories represent common groupings of diagnoses seen in other studies related to hospice care and were created by grouping together relevant medical MSDRG codes in the HCAI inpatient data.

Community Acquired Pneumonia (CAP) is the leading cause of infectious death and the third leading cause of death globally. Disease severity and outcomes are highly variable, dependent on host factors (such as age, smoking history, frailty and comorbidities), microbial factors (the causative organism) and what treatments are given. Clinical decision pathways are complex and despite guidelines, there is significant national variability in how guidelines are adhered to and patient outcomes.

For clinicians treating pneumonia in the hospital setting, care of these patients can be challenging. Key decisions include the type of antibiotics (oral or intravenous), the appropriate place of care (home, hospital or intensive care), and when it is appropriate to stop antibiotics. Decision support tools to help inform clinical management would be highly valuable to the clinical community.

This dataset is synthetic, formed from statistical modelling using real patient data, and represents a population with significant diversity in terms of patient demography, socio-economic status, CAP severity, treatments and outcomes. It can be used to develop code for deployment on real data, train data analysts and increase familiarity with this disease and its management.

PIONEER geography: The West Midlands (WM) has a population of 5.9 million & includes a diverse ethnic & socio-economic mix.

EHR. UHB is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds & an expanded 250 ITU bed capacity during COVID. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health”. This synthetic dataset has been modelled to reflect data collected from this EHR.

Scope: A synthetic dataset which has been statistically modelled on all hospitalised patients admitted to UHB with Community Acquired Pneumonia. The dataset includes highly granular patient demographics & co-morbidities taken from ICD-10 & SNOMED-CT codes. Serial, structured data pertaining to process of care including timings, admissions, escalation of care to ITU, discharge outcomes, physiology readings (heart rate, blood pressure, AVPU score and others), blood results and drug prescribing and administration.

Available supplementary data: Matched synthetic controls; ambulance, OMOP data, real patient CAP data. Available supplementary support: Analytics, Model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.

About Dataset

Context:

This dataset simulates patient data from a hospital in the United Arab Emirates (UAE), focusing on diabetes-related diagnoses. It includes demographic information, visit details, and healthcare service times, along with intentional data quality issues such as missing values, duplicates, and inconsistencies. The dataset is designed to reflect real-world healthcare scenarios, making it suitable for practicing data cleaning, analysis, and predictive modeling.

Inspiration:

The dataset was inspired by the need for realistic healthcare data that can be used for training and testing in data science and machine learning. It aims to provide a comprehensive and challenging dataset for learners and professionals to explore healthcare analytics, predictive modeling, and data preprocessing techniques.

Dataset Information:

• Size: 100,000 rows and 13 columns.
• Columns:
  • Visit_Date: Date of the patient's visit (past 2 years).
  • Patient_ID: Unique identifier for each patient (with duplicates).
  • Age: Patient age (0–100 years).
  • Gender: Patient gender (Male, Female, Other, or missing).
  • Diagnosis: Diabetes-related diagnosis (Type 1, Type 2, Prediabetes, Gestational, or missing).
  • Has_Insurance: Insurance status (Yes, No, or missing).
  • Total_Cost: Total cost of the visit in AED (with some invalid negative values).
  • Region: Emirate where the patient is located (e.g., Abu Dhabi, Dubai).
  • Area: Specific location within the emirate (e.g., Al Ain, Palm Jumeirah).
  • Registration time: Time spent during registration (in minutes).
  • Nursing time: Time spent with nursing staff (in minutes).
  • Laboratory time: Time spent in the laboratory (in minutes).
  • Consultation time: Time spent in consultation (in minutes).
  • Pharmacy time: Time spent at the pharmacy (in minutes).

Usage Scenarios:

This dataset can be utilized for a wide range of purposes, including: - Developing and testing healthcare predictive models: Predict diabetes types or patient outcomes based on demographic and visit data. - Practicing data cleaning, transformation, and analysis techniques: Handle missing values, duplicates, and inconsistencies. - Creating data visualizations: Gain insights into healthcare trends, such as the distribution of diabetes types across regions or age groups. - Learning and teaching data science and machine learning concepts: Use the dataset to teach classification, regression, and clustering techniques in a healthcare context.

You can treat it as a Multi-Class Classification Problem and solve it for Diagnosis, which contains 4 categories: - Type 1 Diabetes - Type 2 Diabetes - Prediabetes - Gestational Diabetes

Acknowledgments:

This dataset was created synthetically to mimic real-world healthcare data. Special thanks to the UAE postal code and geographic information used to structure the Region and Area columns.

Image Credit:

Image by [Walid Barghout].

Diagnosis data of patients and patients in hospitals.

The hospital diagnosis statistics are part of the hospital statistics and have been collected annually from all hospitals since 1993. The statistics include information on the main diagnosis (coded according to ICD-10), length of stay, department and selected sociodemographic characteristics such as age, gender and place of residence, among others.

Basic data of hospitals and preventive care or rehabilitation facilities.

The basic data statistics are part of the hospital statistics. The material and personnel resources of hospitals and preventive or rehabilitation facilities and their specialist departments have been reported annually since 1990.

The aggregated data are freely accessible.

1) Data Introduction • Hospital length of stay dataset is part of a hackathon organized by Analytics Vidhya, focusing on healthcare management challenges, particularly in optimizing hospital patient length of stay. This dataset includes detailed information on patient demographics, hospital attributes, and treatment details, which are critical for managing healthcare efficiency.

2) Data Utilization (1) Hospital length of stay data has characteristics that: • The dataset is structured to provide insights into various factors that affect the length of hospital stays. It contains data on numerous variables including patient age, medical conditions, previous admissions, and the type of hospital and care involved. • It supports predictive modeling to help hospitals improve service delivery by accurately forecasting patient stay durations and managing hospital bed occupancy and staffing needs more effectively. (2) Hospital length of stay data can be used to: • Hospital Management: The data can assist in strategic planning and resource allocation, helping hospitals reduce costs while maintaining high care standards. • Research in Healthcare Systems: It serves as a foundational dataset for academic and commercial research aimed at understanding and improving healthcare systems efficiency.

Introduction

AI in Healthcare Statistics: Artificial Intelligence (AI) in healthcare is growing rapidly, helping doctors and healthcare providers improve patient care. AI uses machines and algorithms to analyse data, such as medical records or images, to help diagnose diseases and suggest treatments faster and more accurately. AI technologies like machine learning, natural language processing, and robotic surgery are driving this growth.

AI helps in areas like medical imaging, drug discovery, and personalised treatment, making healthcare more efficient. This technology is transforming healthcare by reducing costs, speeding up diagnoses, and improving the accuracy of treatments, all while supporting healthcare professionals in delivering better care.

This dataset presents the yearly count of registered patients at Primary Health Care Corporation (PHCC) health centers across Qatar, categorized by region and health center name. Covering data from 2020 to 2024, it reflects population trends, health service reach, and patient distribution within the Central, Northern, and Western regions. It supports health planning, resource allocation, and regional healthcare monitoring.Note: blank values indicate newly established health centers, which may not contain data yet.Significant Drops in registered patients across years is due to assignment of centers as only Qatari health care center

Comparison of MyChart-active patients’ demographics to the patients who had visited our hospital at least once while MyChart was available.

The Digital Patient Engagement (DPE) market is experiencing robust growth, driven by the increasing adoption of telehealth, remote patient monitoring, and the rising demand for personalized healthcare experiences. The market, estimated at $15 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 15% from 2025 to 2033, reaching approximately $50 billion by 2033. This expansion is fueled by several key factors: a rising aging population requiring more intensive care, the increasing prevalence of chronic diseases necessitating ongoing monitoring and engagement, and the proactive push by healthcare providers to improve patient outcomes and reduce hospital readmissions. Technological advancements, such as the development of sophisticated mobile health (mHealth) apps and AI-powered patient portals, are further accelerating market growth. The software segment currently dominates the market, but the services segment is expected to witness significant growth due to the increasing need for technical support, integration services, and data analytics. Patient portals and mobile apps are the leading application segments, indicating a clear preference for convenient and accessible digital healthcare solutions. North America currently holds the largest market share, benefiting from early adoption and advanced technological infrastructure, but the Asia Pacific region is expected to witness the fastest growth due to increasing healthcare expenditure and rising smartphone penetration. However, the market also faces challenges. Data privacy and security concerns remain a significant restraint, particularly given the sensitive nature of patient health information. Furthermore, the digital literacy gap among certain patient demographics presents a barrier to widespread adoption. High implementation costs and the need for robust IT infrastructure also impede market penetration, especially in developing regions. To mitigate these challenges, stakeholders are increasingly focusing on robust cybersecurity measures, user-friendly interfaces, and customized solutions tailored to diverse patient needs and technological capabilities. The focus is shifting towards seamless integration of DPE solutions with existing Electronic Health Records (EHR) systems and the adoption of interoperable standards to facilitate data exchange and enhance care coordination. The competitive landscape is characterized by a mix of established technology giants like IBM, Google, and Microsoft, and specialized DPE companies such as Relatient and Vivify Health. These companies are constantly innovating to offer comprehensive and user-friendly solutions to cater to the evolving needs of both healthcare providers and patients.